Curtis Gale Oltmans's Net Worth
Estimate Recalculated Nov 8, 2024 09:33PM EST
Who is Curtis Gale Oltmans
Curtis Gale Oltmans does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Fulcrum Therapeutics, Inc., AVENUE THERAPEUTICS, INC., and ARRAY BIOPHARMA INC.
SEC CIK
Curtis Gale Oltmans's CIK is 0001714982
Past Insider Trading and Trends
2019 was Curtis Gale Oltmans's most active year for acquiring shares with 5 total transactions. Curtis Gale Oltmans's most active month to acquire stocks was the month of November. 2019 was Curtis Gale Oltmans's most active year for disposing of shares, totalling 9 transactions. Curtis Gale Oltmans's most active month to dispose stocks was the month of December. 2019 saw Curtis Gale Oltmans paying a total of $769,734.00 for 86,100 shares, this is the most they've acquired in one year. In 2019 Curtis Gale Oltmans cashed out on 161,100 shares for a total of $1,431,180.66, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
